Ourania Tatsis, EVP, Chief Reg. & Quality Officer at VERTEX PHARMACEUTICALS INC / MA (VRTX), sold 6,022 shares at $475.34 ($2.9M) on 2025-02-27, disclosed to the SEC on 2025-02-28.
Scheduled sale ($2.9M) by EVP, Chief Reg. & Quality Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $479.61 | 4,962 | $2.4M | 82.5% |
| 2 | $475.34 | 530 | $252K | 8.7% |
| 3 | $475.34 | 530 | $252K | 8.7% |
| Total | $478.86 avg | 6,022 | $2.9M | 100% |
| Filing → |
| VRTX | SELL | 2026-02-19 | $472K | — | Filing → |
| VRTX | SELL | 2026-02-18 | $750K | — | Filing → |
| VRTX | SELL | 2026-02-12 | $215K | — | Filing → |